Antimicrobial stewardship policy: time to revisit the strategy?

Area of Science:

• Infectious Diseases
• Public Health
• Clinical Pharmacy

Background:

• Increasing antibiotic prescriptions and multidrug-resistant bacteria pose significant global health threats.
• Current antimicrobial stewardship (AMS) policies aim to reduce antibiotic use but require refinement.
• There's a need to focus AMS efforts on the crucial initial stages of antibiotic prescription.

Purpose of the Study:

• To propose enhanced strategies for antimicrobial stewardship (AMS).
• To highlight the importance of structured clinical pathways in guiding antibiotic prescriptions.
• To emphasize the role of continuous evaluation via medical dashboards for optimizing antibiotic use.

Main Methods:

• Development of structured clinical pathways tailored to regional epidemiology and resources.
• Implementation of a computerized medical dashboard for continuous evaluation of clinical practices.
• Focus on innovative behavioral approaches for clinicians to improve diagnosis-treatment-outcome relationships.

Main Results:

• Structured clinical pathways provide physicians and patients with clear guidance.
• Medical dashboards enable critical review and optimization of prescribing practices.
• Behavioral interventions offer precise data linking diagnosis, therapeutics, and patient outcomes.

Conclusions:

• Optimizing antibiotic use requires a focus on the entire prescribing process, from initial diagnosis to treatment outcome.
• Structured clinical pathways and data-driven evaluation are essential for effective antimicrobial stewardship.
• These approaches are crucial for adapting therapeutic procedures and improving antibiotic use in the face of rising resistance.